133P Personalized circulating tumor DNA (ctDNA) during neoadjuvant therapy (NAT) to predict response in patients (pts) with early-stage breast cancer (eBC)
Title:
133P Personalized circulating tumor DNA (ctDNA) during neoadjuvant therapy (NAT) to predict response in patients (pts) with early-stage breast cancer (eBC)
Author:
George, M. Meghal, T. Patel, E. Litvak, A. Jacoby, S. Yin, F. Shah, S. Leitner, S. Cruz, A.L. Toomey, K. Kalashnikova, E. Watters, R. Omene, C. Rodriguez, A.A. Jabbour, S. Ganesan, S. Toppmeyer, D. Liu, M.C.